clopidogrel has been researched along with endothelin-1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fareed, J; Yang, LH | 1 |
| Miao, F; Wang, XY | 1 |
| Atef, H; Atteia, HH; El-Sherbiny, M; Ibrahim, GA; Makary, S; Mohamed, AS; Mohammad, HMF; Zaitone, SA | 1 |
1 trial(s) available for clopidogrel and endothelin-1
| Article | Year |
|---|---|
Effects of Erigeron injection on vascular endothelium in patients after intracoronary stenting.
Topics: C-Reactive Protein; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Endothelin-1; Endothelium, Vascular; Erigeron; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide; Phytotherapy; Plant Preparations; Platelet Aggregation Inhibitors; Stents; Superoxide Dismutase; Ticlopidine | 2006 |
2 other study(ies) available for clopidogrel and endothelin-1
| Article | Year |
|---|---|
Vasomodulatory action of clopidogrel and ticlopidine.
Topics: Animals; Aorta, Thoracic; Arachidonic Acid; Clopidogrel; Endothelin-1; In Vitro Techniques; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Rabbits; Rats; Serotonin; Ticlopidine; Vasoconstriction | 1997 |
Clopidogrel or prasugrel reduces mortality and lessens cardiovascular damage from acute myocardial infarction in hypercholesterolemic male rats.
Topics: Animals; Cardiovascular System; Clopidogrel; Creatine Kinase, MB Form; Endothelin-1; Gene Expression Regulation; Hypercholesterolemia; Male; Models, Animal; Mortality; Myocardial Infarction; Nitric Oxide Synthase Type III; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction; Treatment Outcome | 2020 |